(1)
Rodzajewska, A.; KuryƂo, W.; Szklener, K. Impressive Clinical Response Following Combined BRAF and MEK Inhibition in a Low-Grade Serous Ovarian Carcinoma Patient With a BRAF V600E Mutation. J Educ Health Sport 2023, 31, 138-147.